Browse every story filed under this topic, curated from trusted publishers around the world.
Lilly touts 'encouraging' early days for Foundayo obesity launch, even as GLP-1 pill appears to lag Novo's
As Eli Lilly gets off to the races with the launch of its flagship oral GLP-1 Foundayo, the Indianapolis drugmaker—and at least one set of analysts—isn’t sweating what appears to be a slower-than-expected liftoff compared with …
Read full story →
STAT+: FDA wants to exclude weight-loss drugs from a compounding list
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs …
Eli Lilly profits more than double as weight-loss drug sales soar
First-quarter sales of medication Zepbound increased 80 per cent to $4.2bn
Watch Eli Stowers get emotional after NFL draft call from Eagles' Howie Roseman
Watch Philadelphia Eagles tight end draft pick Eli Stowers become emotional when hearing he was selected in the NFL draft.
Eli Lilly bets on recombinases in $2.25bn Profluent R&D pact
Eli Lilly and Profluent will harness AI to discover and develop recombinases for precise, large-scale gene editing.
Eli Junior Kroupi gives Manchester City green light ahead of £80M transfer talks
Cherries will demand £80M for Eli Junior Kroupi; Liverpool, Chelsea & Man City all interestedThe 19-year-old has no release clause …
Who are OU football's top 2027 NFL Draft prospects? We examine Sooners
Oklahoma football has several players who could be selected in the 2027 NFL Draft, including David Stone, Eli Bowen and …
Eli Lilly signs $2.3b AI biotech deal with Profluent
Lilly has signed at least 15 AI deals in the past five years, boosting its AI drug discovery efforts.
Steelers invite fan favorite to rookie minicamp
The Steelers drafted Eli Heidenreich in the seventh round of the 2026 NFL draft and invited teammate
STAT+: Boehringer’s obesity drug shows 16.6% weight loss; more data needed
Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and more biotech news today
STAT+: Eli Lilly enlists AI startup for next-generation gene editors
Eli Lilly's deal with Profluent aims to go beyond CRISPR by using AI-designed enzymes to insert entire genes. It could …
Eli Lilly outlays $2.3bn to acquire blood cancer specialist Ajax Therapeutics
Ajax’s lead asset is AJ1-11095, a once-daily Type II JAK2 inhibitor taken orally, which is currently in a Phase I …
Newcastle like Bournemouth striker Eli Junior Kroupi
Newcastle are interested in signing Bournemouth striker Eli Junior Kroupi, as the Magpies look to rectify their issues at the …
Pittsburgh community celebrates Steelers selecting native Eli Heidenreich
Emotions ran high on Saturday when Pittsburgh native Eli Heidenreich heard his name called in the NFL Draft.
Check out the moment Eli Heidenreich found out he was a Steeler
It was an amazing moment, bigger than football when Navy running back Eli Heidenreich got the call from the Steelers.
4 winners and losers from Patriots drafting Gabe Jacas and Eli Raridon
New England selected two players on Day 2 of the NFL Draft.
Instant grades for the Patriots drafting TE Eli Raridon in Round 3
Quick-hit reaction to the Patriots’ third pick in the 2026 NFL Draft.
Patriots draft Eli Raridon, TE, Notre Dame with the 95th pick in Round 3
The Patriots have made their third selection in the 2026 NFL Draft.
Eagles draft Eli Stowers: Fantasy impact of a boom-or-bust player with future TE1 potential
A high-upside, athletic tight end lands in a crowded situation that limits his short-term Fantasy value
STAT+: A biotech VC on what Eli Lilly saw in a struggling cancer startup for $3.2B
What did Eli Lilly see in a struggling biotech startup that made the pharma giant want to pay billions for …
You've seen all articles for #eli.
Check back
soon
for new stories.